Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
This distinction can significantly impact a patients daily routine and overall treatment experience
Type: Company Headquarters, U.S.FDA Department issuing Warning: Center for Drug Evaluation and Research (CDER)Warning Letter Date: March 5, 2026Facility Location: Plainsboro, New JerseyDate(s) of Inspections: January 13 to February 7 of 2025
,
Presentation of Results The results are presented in a narrative report that summarizes the extracted data
Blend Composition PEPTIDE COMPONENTS BPC-157: 5mg (50%) TB-500: 5mg (50%) Ratio: 1:1 Equal blend Total Peptide: 10mg PHYSICAL PROPERTIES Form: White lyophilized powder Solubility: Readily dissolves in water Stability: Excellent when stored properly Storage: Keep refrigerated 3646 F (28 C)
